Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
US8778402B2 · kind B2 · utility
8Cited by
1References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 24, 2013 |
| Grant date | Jul 15, 2014 |
| Priority date | — |
| Expiry date | Jan 24, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Dry powder formulations comprising a corticosteroid and a beta2-adrenergic drug in combination are useful for the prevention and/or treatment of inflammatory or obstructive airways diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.